Table of Content

Table of Contents

Global Bi-Specific MAbS Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Bi-Specific MAbS Market by Value
2.2.1 Global Bi-Specific MAbS Revenue by Type
2.2.2 Global Bi-Specific MAbS Market by Value (%)
2.3 Global Bi-Specific MAbS Market by Production
2.3.1 Global Bi-Specific MAbS Production by Type
2.3.2 Global Bi-Specific MAbS Market by Production (%)

3. The Major Driver of Bi-Specific MAbS Industry
3.1 Historical & Forecast Global Bi-Specific MAbS Demand
3.2 Largest Application for Bi-Specific MAbS (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Bi-Specific MAbS Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Bi-Specific MAbS Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Bi-Specific MAbS Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Bi-Specific MAbS Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Bi-Specific MAbS Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Bi-Specific MAbS Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Bi-Specific MAbS Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Bi-Specific MAbS Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Bi-Specific MAbS Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Bi-Specific MAbS Average Price Trend
12.1 Market Price for Each Type of Bi-Specific MAbS in US (2018-2022)
12.2 Market Price for Each Type of Bi-Specific MAbS in Europe (2018-2022)
12.3 Market Price for Each Type of Bi-Specific MAbS in China (2018-2022)
12.4 Market Price for Each Type of Bi-Specific MAbS in Japan (2018-2022)
12.5 Market Price for Each Type of Bi-Specific MAbS in India (2018-2022)
12.6 Market Price for Each Type of Bi-Specific MAbS in Korea (2018-2022)
12.7 Market Price for Each Type of Bi-Specific MAbS in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Bi-Specific MAbS Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Bi-Specific MAbS

14. Bi-Specific MAbS Competitive Landscape
14.1 Johnson and Johnson
14.1.1 Johnson and Johnson Company Profiles
14.1.2 Johnson and Johnson Product Introduction
14.1.3 Johnson and Johnson Bi-Specific MAbS Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Novartis AG
14.2.1 Novartis AG Company Profiles
14.2.2 Novartis AG Product Introduction
14.2.3 Novartis AG Bi-Specific MAbS Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Hoffmann-La Roche Ltd.
14.3.1 Hoffmann-La Roche Ltd. Company Profiles
14.3.2 Hoffmann-La Roche Ltd. Product Introduction
14.3.3 Hoffmann-La Roche Ltd. Bi-Specific MAbS Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Chugai Pharmaceutical
14.4.1 Chugai Pharmaceutical Company Profiles
14.4.2 Chugai Pharmaceutical Product Introduction
14.4.3 Chugai Pharmaceutical Bi-Specific MAbS Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Bayer AG
14.5.1 Bayer AG Company Profiles
14.5.2 Bayer AG Product Introduction
14.5.3 Bayer AG Bi-Specific MAbS Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Thermo Fisher Scientific
14.6.1 Thermo Fisher Scientific Company Profiles
14.6.2 Thermo Fisher Scientific Product Introduction
14.6.3 Thermo Fisher Scientific Bi-Specific MAbS Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Bistro-Myers Squibb
14.7.1 Bistro-Myers Squibb Company Profiles
14.7.2 Bistro-Myers Squibb Product Introduction
14.7.3 Bistro-Myers Squibb Bi-Specific MAbS Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Mylan N.V.
14.8.1 Mylan N.V. Company Profiles
14.8.2 Mylan N.V. Product Introduction
14.8.3 Mylan N.V. Bi-Specific MAbS Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Daiichi Sankyo Company
14.9.1 Daiichi Sankyo Company Company Profiles
14.9.2 Daiichi Sankyo Company Product Introduction
14.9.3 Daiichi Sankyo Company Bi-Specific MAbS Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Abbott
14.10.1 Abbott Company Profiles
14.10.2 Abbott Product Introduction
14.10.3 Abbott Bi-Specific MAbS Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 AstraZeneca
14.12 Eli Lilly
14.13 Merck and Co.
14.14 Amgen
14.15 Pfizer
14.16 GlaxoSmithKline plc
14.17 Roche
15. Conclusion
16. Methodology and Data Source

List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Bi-Specific MAbS Industry (Volume)
Figure 2. Bi-Specific MAbS Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Bi-Specific MAbS Revenue in 2022
Figure 5. US Bi-Specific MAbS Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Bi-Specific MAbS Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Bi-Specific MAbS Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Bi-Specific MAbS Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Bi-Specific MAbS Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Bi-Specific MAbS Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Bi-Specific MAbS Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Bi-Specific MAbS Revenue, by Type (Million USD) (2018-2028)
Table 4. Bi-Specific MAbS Production, by Type (K Unit) (2018-2028)
Table 5. Bi-Specific MAbS Demand (K Unit) by Application (2018-2028)
Table 6. Bi-Specific MAbS Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Bi-Specific MAbS Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Bi-Specific MAbS Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Bi-Specific MAbS Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Bi-Specific MAbS Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Bi-Specific MAbS Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Bi-Specific MAbS Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Bi-Specific MAbS Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Bi-Specific MAbS Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Bi-Specific MAbS in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Bi-Specific MAbS in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Bi-Specific MAbS in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Bi-Specific MAbS in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Bi-Specific MAbS in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Bi-Specific MAbS in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Bi-Specific MAbS in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Johnson and Johnson Profiles
Table 61. Johnson and Johnson Bi-Specific MAbS Product Introduction
Table 62. Johnson and Johnson Bi-Specific MAbS Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Johnson and Johnson Strategic initiatives
Table 64. Novartis AG Profiles
Table 65. Novartis AG Bi-Specific MAbS Product Introduction
Table 66. Novartis AG Bi-Specific MAbS Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Novartis AG Strategic initiatives
Table 68. Hoffmann-La Roche Ltd. Profiles
Table 69. Hoffmann-La Roche Ltd. Bi-Specific MAbS Product Introduction
Table 70. Hoffmann-La Roche Ltd. Bi-Specific MAbS Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Hoffmann-La Roche Ltd. Strategic initiatives
Table 72. Chugai Pharmaceutical Profiles
Table 73. Chugai Pharmaceutical Bi-Specific MAbS Product Introduction
Table 74. Chugai Pharmaceutical Bi-Specific MAbS Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Chugai Pharmaceutical Strategic initiatives
Table 76. Bayer AG Profiles
Table 77. Bayer AG Bi-Specific MAbS Product Introduction
Table 78. Bayer AG Bi-Specific MAbS Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Bayer AG Strategic initiatives
Table 80. Thermo Fisher Scientific Profiles
Table 81. Thermo Fisher Scientific Bi-Specific MAbS Product Introduction
Table 82. Thermo Fisher Scientific Bi-Specific MAbS Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Thermo Fisher Scientific Strategic initiatives
Table 84. Bistro-Myers Squibb Profiles
Table 85. Bistro-Myers Squibb Bi-Specific MAbS Product Introduction
Table 86. Bistro-Myers Squibb Bi-Specific MAbS Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Bistro-Myers Squibb Strategic initiatives
Table 88. Mylan N.V. Profiles
Table 89. Mylan N.V. Bi-Specific MAbS Product Introduction
Table 90. Mylan N.V. Bi-Specific MAbS Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Mylan N.V. Strategic initiatives
Table 92. Daiichi Sankyo Company Profiles
Table 93. Daiichi Sankyo Company Bi-Specific MAbS Product Introduction
Table 94. Daiichi Sankyo Company Bi-Specific MAbS Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Daiichi Sankyo Company Strategic initiatives
Table 97. Abbott Profiles
Table 98. Abbott Bi-Specific MAbS Product Introduction
Table 99. Abbott Bi-Specific MAbS Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Abbott Strategic initiatives
Table 101. AstraZeneca Profiles
Table 102. AstraZeneca Bi-Specific MAbS Product Introduction
Table 103. AstraZeneca Bi-Specific MAbS Production (Unit), Revenue (Million USD) (2018-2022)
Table 104. AstraZeneca Strategic initiatives
Table 105. Eli Lilly Profiles
Table 106. Eli Lilly Bi-Specific MAbS Product Introduction
Table 107. Eli Lilly Bi-Specific MAbS Production (Unit), Revenue (Million USD) (2018-2022)
Table 108. Eli Lilly Strategic initiatives
Table 109. Merck and Co. Profiles
Table 110. Merck and Co. Bi-Specific MAbS Product Introduction
Table 111. Merck and Co. Bi-Specific MAbS Production (Unit), Revenue (Million USD) (2018-2022)
Table 112. Merck and Co. Strategic initiatives
Table 113. Amgen Profiles
Table 114. Amgen Bi-Specific MAbS Product Introduction
Table 115. Amgen Bi-Specific MAbS Production (Unit), Revenue (Million USD) (2018-2022)
Table 116. Amgen Strategic initiatives
Table 117. Pfizer Profiles
Table 118. Pfizer Bi-Specific MAbS Product Introduction
Table 119. Pfizer Bi-Specific MAbS Production (Unit), Revenue (Million USD) (2018-2022)
Table 120. Pfizer Strategic initiatives
Table 121. GlaxoSmithKline plc Profiles
Table 122. GlaxoSmithKline plc Bi-Specific MAbS Product Introduction
Table 123. GlaxoSmithKline plc Bi-Specific MAbS Production (Unit), Revenue (Million USD) (2018-2022)
Table 124. GlaxoSmithKline plc Strategic initiatives
Table 125. Roche Profiles
Table 126. Roche Bi-Specific MAbS Product Introduction
Table 127. Roche Bi-Specific MAbS Production (Unit), Revenue (Million USD) (2018-2022)
Table 128. Roche Strategic initiatives